Recce Pharmaceuticals Ltd. (R9Q) Financial Statements
Recce Pharmaceuticals Ltd. Financial Overview
Recce Pharmaceuticals Ltd.'s market cap is currently $69.06M. The company's EPS TTM is $-0.05; its P/E ratio is -6.95; Recce Pharmaceuticals Ltd. has not announced its next earnings date. See an overview of income statement, balance sheet, and cash flow financials.
| Jun 26 | Jun 25 | Jun 24 | Jun 23 | Jun 22 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 0.00 | $ 7.51M | $ 5.03M | $ 4.37M | $ 3.08M |
| Gross Profit | $ -356.40K | $ -2.94M | $ -2.19M | $ 4.15M | $ 2.90M |
| Operating Income | $ -23.16M | $ -22.88M | $ -22.05M | $ -17.33M | $ -14.15M |
| EBITDA | $ -22.81M | $ -20.05M | $ -21.35M | $ -16.99M | $ -13.87M |
| Net Income | $ -14.96M | $ -21.43M | $ -17.66M | $ -13.08M | $ -10.99M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 2.69M | $ 10.45M | $ 4.42M | $ 1.56M | $ 11.58M |
| Total Assets | $ 8.53M | $ 12.41M | $ 6.37M | $ 2.56M | $ 12.62M |
| Total Debt | $ 10.44M | $ 10.77M | $ 811.19K | $ 250.57K | $ 74.76K |
| Net Debt | $ 7.75M | $ 319.44K | $ -3.60M | $ -1.31M | $ -11.51M |
| Total Liabilities | $ 25.25M | $ 15.47M | $ 15.89M | $ 5.14M | $ 2.56M |
| Stockholders' Equity | $ -16.72M | $ -3.05M | $ -9.52M | $ -2.59M | $ 10.06M |
| Cash Flow | |||||
| Free Cash Flow | $ -9.95M | $ -20.47M | $ -13.15M | $ -12.73M | $ -9.05M |
| Operating Cash Flow | $ -9.89M | $ -20.44M | $ -13.01M | $ -12.69M | $ -9.01M |
| Investing Cash Flow | $ 123.60K | $ -443.90K | $ -141.90K | $ -38.63K | $ -40.34K |
| Financing Cash Flow | $ 2.01M | $ 26.92M | $ 16.00M | $ 2.71M | $ -240.50K |
Currency in AUD